Trial
NCT01367444
Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Sanofi
Collaborators
—
Condition
Stargardt's Disease
Intervention
SAR422459
Why stopped
Study stopped not for safety reasons. Due to review of clinical development plans and priorities, Sponsor decided to stop development of the product.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-14